Rigel Pharmaceuticals | RIGL - الأصول





الأصول تغيير تاريخ
Agenus USD 172.69M 13.76M 2026-06
Amgen USD 95.64B 3.14B 2026-06
Anika Therapeutics USD 183.47M 4.09M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Celldex Therapeutics USD 782.35M 271.09M 2026-06
Daiichi Sankyo JPY 4.11T 109.16B 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Heron Therapeutics USD 252.26M 6.05M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Ligand Pharmaceuticals USD 2.19B 653.77M 2026-06
MacroGenics USD 345.41M 127.54M 2026-06
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
Veracyte USD 1.49B 49.97M 2026-06